EDGAR Filing Documents for 0001532176-13-000030

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001532176-13-000030

Filing Date

2013-11-05

Accepted

2013-11-05 07:14:08

Documents

Period of Report

2013-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	regn-93013x10q.htm	10-Q	1724464
2	CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)	regn-ex_311x9302013x10q.htm	EX-31.1	15907
3	CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)	regn-ex_312x9302013x10q.htm	EX-31.2	16271
4	CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350	regn-ex_32x9302013x10q.htm	EX-32	7312
	Complete submission text file	0001532176-13-000030.txt		8254709

Data Files

Seq	Description	Document	Type	Size
5	XBRL INSTANCE DOCUMENT	regn-20130930.xml	EX-101.INS	1349728
6	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	regn-20130930.xsd	EX-101.SCH	36930
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	regn-20130930_cal.xml	EX-101.CAL	70584
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	regn-20130930_def.xml	EX-101.DEF	223699
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	regn-20130930_lab.xml	EX-101.LAB	506144
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	regn-20130930_pre.xml	EX-101.PRE	276334

Mailing Address

Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000

REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)